The effect of collagenase and hyaluronidase on transient perfusion in human osteosarcoma xenografts grown orthotopically and in dorsal skinfold chambers

Anticancer Research

Volumn 27, Issue 3 B, 2007, Pages 1475-1481

  Tufto, Ingunn ^a   Hansen, Robert ^a   Byberg, David ^a   Nygaard, Kirsten H H ^a   Tufto, Jarle ^a   Davies, Catharina De L ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Collagenase; Extracellular matrix; Hyaluronidase; Transient perfusion; Vascular network

Indexed keywords

COLLAGENASE; HYALURONIDASE;

ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; MOUSE; NONHUMAN; OSTEOSARCOMA; PERFUSION; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; BONE NEOPLASMS; CAPILLARIES; COLLAGENASES; FEMALE; HUMANS; HYALURONOGLUCOSAMINIDASE; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; OSTEOSARCOMA; PERFUSION; REGIONAL BLOOD FLOW; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 34249294519     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Intaglietta M, Myers RR, Gross JF and Reinhold HS: Dynamics of microvascular flow in implanted mouse mammary tumours. Bibl Anat 15: 273-276, 1977.
2. Reinhold HS, Blachiwiecs B and Blok A: Oxygenation and reoxygenation in 'sandwich' tumours. Bibl Anat 15: 270-272, 1977.
3. Young SD, Marshall RS and Hill RP: Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA 85: 9533-9537, 1988.
4. Brekken C, Hjelstuen MH, Bruland ØS and Davies C de L: Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts. Anticancer Res 20: 3513-3535, 2000.
5. Eikenes L, Bruland ØS, Brekken C and Davies C de L: Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts. Cancer Res 64: 4768-4773, 2004.
6. Eikenes L, Tari M, Tufto I, Bruland ØS and Davies C de L: Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx™) in human osteosarcoma xenograft. Br J Cancer 93: 81-88, 2005.
7. Davies CdeL, Rønning LM and Eikenes L: Hyaluronidase and collagenase affect the interstitial diffusion of macromolecules. In: Proceedings of the 95th Annual meeeting of the American Association for Cancer Research, Orlando, USA 45: 277, 2004.
8. Trotter MJ, Chaplin DJ, Durand RE and Olive PL: The use of fluorescent probes to identify regions of transient perfusion in murine tumors. Int J Radiat Oncol Biol Phys 16: 931-934, 1989.
9. Trotter MJ, Chaplin DJ and Olive PL: Possible mechanisms for intermittent blood flow in the murine SCCVII carcinoma. Int J Radiat Biol 60: 139-146, 1991.
10. Fodstad Ø, Brøgger A, Bruland ØS, Solheim ØP, Nesland JM and Pihl A: Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma. Int J Cancer 38: 33-40, 1986.
11. Brekken C, Bruland Ø and Davies C de L: Interstitial fluid pressure in human osteosarcoma xenografts: Significance of implantation site and the response to intratumoral injection of hyaluronidase. Anticancer Res 20: 3503-3512, 2000.
12. Endrich B, Asaishi K, Goetz A and Messmer K: Technical report - a new chamber technique for microvascular studies in unanesthetized hamsters. Res Exp Med 177: 125-134, 1980.
13. Trotter MJ, Chaplin DJ and Olive PL: Use of a carbocyanine dye as a marker of functional vasculature in murine tumours. Br J Cancer 59: 706-709, 1989.
14. Trotter MJ, Olive PL and Chaplin DJ: Effect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse. Br J Cancer 62: 903-908, 1990.
15. McCullagh P and Nelder JA: Generalized linear models. Chapman and Hall, London, 1989.
16. Tufto I and Rofstad EK: Transient perfusion in human melanoma xenografts. Br J Cancer 71: 789-793, 1995.
17. Thomas CD, Stern S, Chaplin DJ and Guichard M: Transient perfusion and radiosensitizing effect after nicotinamide, carbogen, and perflubron emulsion administration. Radiother Oncol 39: 235-241, 1996.
18. Chaplin DJ, Horsman MR and Trotter MJ: Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor. J Natl Cancer Inst 82: 672-676, 1990.
19. Horsman MR, Nordsmark M, Khalil AA, Hill SA, Chaplin DJ, Siemann DW and Overgaard J: Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing. Acta Oncol 33: 371-376, 1994.
20. Adamson RH: Permeability of frog mesentric capillaries after partial pronase digestion of the endothelial glycocalyx. J Physiol 428: 1-13, 1990.
21. Weinberg PD, Carney SL, Winlove CP and Parker KH: The contributions of glycosaminoglycans, collagen and other interstitial components to the hydraulic resistivity of porcine aortic wall. Connect Tissue Res 36: 297-308, 1997.
22. Qiao R, Wang H, Yan W, Odekon LE, Del Vecchio PJ, Smith TJ and Malik AB: Extracellular matrix hyaluronan is a determinant of the endothelial barrier. Am J Physiol 269: C103-C109, 1995.
23. Henry CBS and Duling BR: Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol 277: H508-H514, 1999.
24. Huxley V and Williams DA: Role of glycocalyx on coronary arteriole permeability to proteins: evidence from enzyme treatments. Am J Physiol Heart Circ Physiol 278: H1177-H1185, 2000.
25. van Haaren P, VanBavel E, Vink H and Spaan JAE: Localization of the permeability barrier to solutes in isolated arteries by confocal microscopy. Am J Physiol Heart Circ Physiol 285: H2848-H2856, 2003.
26. Dewhirst MW, Kimura H, Rehmus SW, Braun RD and Papahadjopoulos D: Microvascular studies on the origins of perfusion-limited hypoxia. Br J Cancer 27: S247-S251, 1996.
27. Chaplin DJ, Olive PL and Durand RE: Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res 47: 597-601, 1987.
28. Luk CK, Veinot-Drebot L, Tjan E and Tannock IF: Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines. J Natl Cancer Inst 82: 684-692 1990.
29. Jain RK: Delivery of molecular and cellular medicine to solid tumors. Adv Drug deliv Rev 46: 149-168, 2001.
30. Baumgartner G: Hyaluronidase in the therapy of malignant diseases. Wien Klin Wochenschr Suppl 174: 1-22, 1987.
31. Maier U and Baumgartner G: Metaphylatic effect of mitomycin C with and without hyaluronidase after transurethal resection of bladder cancer: randomized trial. J Urol 141: 529-530, 1989.
32. Smith KJ, Skelton HG, Turansky G and Wagner KF: Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. J Am Acad Dermatol 36: 239-242, 1997.
33. Curran S and Murray GI: Matrix metalloproteinases in tumor invasion and metastasis. J Pathol 189: 300-308, 1999.
34. Stamenkovic I: Extracellular matrix modelling: the role of matrix metalloproteinases. J Pathol 200: 448-464, 2003.